Kerun biology is a science and technology company focusing on the research and development of innovative drugs of biological macromolecules. It is committed to the research and development of innovative drugs accessible to patients, in order to provide patients with safe, effective and accessible high-quality biological drugs, and provide comprehensive innovative treatment schemes to meet the clinical needs that need to be solved urgently.

The company has established a number of mature drug R & D technology platforms with its own characteristics. Relying on the innovation and differentiation advantages of the technology platform, the company has successfully developed a number of exclusive biological drugs in the domestic market, including three new drugs of biological products, six domestic invention patents and one international patent. It has successively undertaken many national key projects, such as the creation of major new drugs in the eleventh five year plan, major special projects of the national development and Reform Commission, the innovation fund of the Ministry of science and technology and so on.

The company has a united and efficient R & D management team and first-class international expert resources; Members of the core technical team have more than 10 years of experience in new drug R & D. at present, the company is implementing innovation transformation and cooperating with Chinese scientists with international vision to carry out cooperation in innovative biological drugs and platform construction. The company attaches great importance to cooperation and exchange with the industry, has accumulated a large number of industry resources, and has formed a good partnership with many excellent large pharmaceutical enterprises in China.

Looking forward to the future, Kerun biology will make unremitting efforts to develop more drugs to meet clinical needs and solve diseases, contribute "Kerun wisdom" and escort human health.